New developments around histamine H₃receptor antagonists/inverse agonists: a patent review (2010 – present)

JOURNAL ARTICLE published January 2014 in Expert Opinion on Therapeutic Patents

Authors: Dorota Łażewska | Katarzyna Kieć-Kononowicz

Malaria transmission blocking compounds: a patent review

JOURNAL ARTICLE published 3 June 2022 in Expert Opinion on Therapeutic Patents

Authors: Sara Consalvi | Chiara Tammaro | Federico Appetecchia | Mariangela Biava | Giovanna Poce

GlaxoSmithKline’s CCR3 chemokine receptor antagonists

JOURNAL ARTICLE published April 2004 in Expert Opinion on Therapeutic Patents

Novel activators of dendritic cells as fundamental tools in immunotherapy

JOURNAL ARTICLE published September 2001 in Expert Opinion on Therapeutic Patents

Authors: Stefania Gallucci

Engraftable human neural stem cells

JOURNAL ARTICLE published April 2000 in Expert Opinion on Therapeutic Patents

Annotated Patent Selections

JOURNAL ARTICLE published 2004 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published October 2005 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published August 2006 in Expert Opinion on Therapeutic Patents

Annotated Patent Selections

JOURNAL ARTICLE published March 2000 in Expert Opinion on Therapeutic Patents

Editorial Biologicals & Immunologicals: Patenting combinatorial libraries and associated technologies

JOURNAL ARTICLE published September 1996 in Expert Opinion on Therapeutic Patents

Authors: Christopher G Newton

Semisynthetic derivatives of mannopeptimycin antibiotics active against multi-drug resistant Gram-positive bacteria

JOURNAL ARTICLE published August 2003 in Expert Opinion on Therapeutic Patents

New long acting β₂agonists

JOURNAL ARTICLE published February 2003 in Expert Opinion on Therapeutic Patents

Novel crystalline form of 3,5-dibromo-N-[(2S)- 2-(-4-fluorophenyl)-4- (3-morpholin-4-ylaztidin-1-yl)butyl]-N-methylbenzamide

JOURNAL ARTICLE published February 2008 in Expert Opinion on Therapeutic Patents

Authors: Peter Norman

Phenyl acetic acid derivatives as inhibitors of leukotriene synthesis

JOURNAL ARTICLE published October 1994 in Expert Opinion on Therapeutic Patents

British Biotech: how much value is there in metalloproteinase inhibitors?

JOURNAL ARTICLE published July 1997 in Expert Opinion on Therapeutic Patents

Authors: Sandy M Thomas | Reuben Falkenherr | Julian F Burke

Diabetes area patent participation analysis – part II: years 2011-2016

JOURNAL ARTICLE published February 2018 in Expert Opinion on Therapeutic Patents

Authors: Markus Boehm | Matthew Crawford | Jamie E. Moscovitz | Philip A. Carpino

Anti-aggregatory drugs: I. Platelet receptor antagonists

JOURNAL ARTICLE published October 1999 in Expert Opinion on Therapeutic Patents

Authors: Jörg Geiger

N-Acylphenylalanines as antagonists of VLA-4/VCAM-1

JOURNAL ARTICLE published October 1999 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published September 2006 in Expert Opinion on Therapeutic Patents

N-substituted quinuclidinol esters as potential therapeutic antimuscarinic agents

JOURNAL ARTICLE published 2003 in Expert Opinion on Therapeutic Patents